---
layout: default
title: "Enrique de Álava"
permalink: /faculty/edealava/

---

## Prof. Enrique de Álava MD, PhD. 
[Enrique de Álava](https://scholar.google.com/citations?user=fCdcCN4AAAAJ&hl=en&oi=sra) (Pamplona, Spain, 1964) is a Pathologist with a special interest in Bone and soft tissue Pathology, and Molecular Pathology. He chaired the Spanish Society of Pathology, the Spanish Division of the International Academy of Pathology between May 2015 and May 2017.
Enrique de Álava obtained a degree in Medicine and Surgery at the University of Navarra in 1988, finishing his training as a specialist in Pathology in 1993 at the University Clinic of Navarra. He has a Ph.D. in Medicine and Surgery from the University of Navarra (1993). He completed his postdoctoral training in the Department of Pathology at Memorial Sloan Kettering Cancer Center in New York, in the laboratory of William Gerald, from 1994 to 1996, thanks to a postdoctoral fellowship from the Spanish Ministry of Education and Science.
Enrique de Álava becomes a tenured research scientist of the Spanish Research Council (CSIC) in 2003 and became a Principal Investigator of the Laboratory of Molecular Pathology at the Cancer Research Center of Salamanca, Spain, coordinator of the Regional Biobank of Castilla and León, and Deputy Director of the National DNA Biobank. In 2009 he was promoted to CSIC Full Research Professor. In July 2010 he joined the Department of Pathology, University Hospital of Salamanca, as an Attending Pathologist.
His research objectives are the search and validation of new therapeutic targets, mechanisms of sarcoma genesis, and validation of new diagnostic tools directly applicable in the hospital routine. He has obtained in the last 5 years competitive funding from the European Commission, the Institute of Health Carlos III, and the Scientific Foundation of the AECC (Spanish Association Against Cancer). He has also got private funds from six different charities, PharmaMar, Pfizer, Astra-Zeneca, Roche, and Dako-Agilent. He is also leading (2013-2018) a consortium that has a stable cooperative project funded by the AECC on Ewing sarcoma.
He is active in Tweeter as @EnriquedeAlava as a personal account, or as @PathologyHUVR and @LabHUVR as professional accounts.

[![Twitter URL](https://img.shields.io/twitter/url/https/twitter.com/bukotsunikki.svg?style=social&label=Follow%20%40EnriquedeAlava)](https://twitter.com/EnriquedeAlava)
